Taken together, Wnt5A-controlled PKA/β-catenin signaling regulate upregulation of ABCB1, cyclin D1, c-Myc and VEGF in MDR cancer cells for increased survival advantage under chemotherapeutic treatment. This evidence concerns the gene WNT5A and cancer.